Display options
Share it on

Brain Imaging Behav. 2021 May 21; doi: 10.1007/s11682-021-00475-y. Epub 2021 May 21.

Effect of chemotherapy on default mode network connectivity in older women with breast cancer.

Brain imaging and behavior

Bihong T Chen, Zikuan Chen, Sunita K Patel, Russell C Rockne, Chi Wah Wong, James C Root, Andrew J Saykin, Tim A Ahles, Andrei I Holodny, Can-Lan Sun, Mina S Sedrak, Heeyoung Kim, Ashley Celis, Vani Katheria, William Dale

Affiliations

  1. Department of Diagnostic Radiology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA, 91010, USA. [email protected].
  2. Center for Cancer and Aging, City of Hope National Medical Center, Duarte, CA, 91010, USA. [email protected].
  3. Department of Diagnostic Radiology, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA, 91010, USA.
  4. Department of Population Science, City of Hope National Medical Center, Duarte, CA, 91010, USA.
  5. Division of Mathematical Oncology, City of Hope National Medical Center, Duarte, CA, 91010, USA.
  6. Applied AI and Data Science, City of Hope National Medical Center, Duarte, CA, 91010, USA.
  7. Neurocognitive Research Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  8. Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA.
  9. Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  10. Center for Cancer and Aging, City of Hope National Medical Center, Duarte, CA, 91010, USA.
  11. Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, 91010, USA.
  12. Department of Supportive Care Medicine, City of Hope National Medical Center, Duarte, CA, 91010, USA.

PMID: 34019223 PMCID: PMC8606014 DOI: 10.1007/s11682-021-00475-y

Abstract

Chemotherapy may impair cognition and contribute to accelerated aging. The purpose of this study was to assess the effects of chemotherapy on the connectivity of the default mode network (DMN) in older women with breast cancer. This prospective longitudinal study enrolled women aged ≥ 60 years with stage I-III breast cancer (CTx group) and matched healthy controls (HC group). Study assessments, consisting of resting-state functional MRI (rs-fMRI) and the Picture Sequence Memory (psm) test for episodic memory from the NIH Toolbox for Cognition, were obtained at baseline and within one month after the completion of chemotherapy for the CTx group and at matched intervals for the HC group. Two-sample t-test and FDR multiple comparison were used for statistical inference. Our analysis of the CTx group (N = 19; 60-82 years of age, mean = 66.6, SD = 5.24) compared to the HC group (N = 14; 60-78 years of age, mean = 68.1, SD = 5.69) revealed weaker DMN subnetwork connectivity in the anterior brain but stronger connectivity in the posterior brain at baseline. After chemotherapy, this pattern was reversed, with stronger anterior connectivity and weaker posterior connectivity. In addition, the meta-level functional network connectivity (FNC) among the DMN subnetworks after chemotherapy was consistently weaker than the baseline FNC as seen in the couplings between anterior cingulate cortex (ACC) and retrosplenial (rSplenia) region, with ΔFNC('ACC','rSplenia')=-0.14, t value=-2.44, 95 %CI=[-0.27,-0.10], p

Keywords: Breast cancer; Cancer‐related cognitive impairment (CRCI); Chemotherapy; Default mode network; Episodic memory

References

  1. J Neurosci. 2018 Mar 14;38(11):2809-2817 - PubMed
  2. J Geriatr Oncol. 2020 Mar;11(2):290-296 - PubMed
  3. Neurobiol Aging. 2014 Sep;35 Suppl 2:S11-9 - PubMed
  4. J Clin Oncol. 2018 Oct 3;:JCO1800140 - PubMed
  5. Breast Cancer Res Treat. 2019 Jul;176(1):181-189 - PubMed
  6. J Natl Cancer Inst. 2019 Dec 1;111(12):1245-1254 - PubMed
  7. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82 - PubMed
  8. Brain Behav Immun. 2013 Mar;30 Suppl:S117-25 - PubMed
  9. Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Apr;83(4 Pt 1):041906 - PubMed
  10. Psychooncology. 2018 Jan;27(1):3-9 - PubMed
  11. Front Neurosci. 2018 Feb 02;12:15 - PubMed
  12. Semin Oncol. 2013 Dec;40(6):709-25 - PubMed
  13. Annu Rev Psychol. 2019 Jan 4;70:219-243 - PubMed
  14. J Natl Cancer Inst. 2021 Feb 1;113(2):112-122 - PubMed
  15. Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11600-5 - PubMed
  16. Nat Rev Cancer. 2007 Mar;7(3):192-201 - PubMed
  17. Front Hum Neurosci. 2017 Nov 15;11:555 - PubMed
  18. Brain Imaging Behav. 2019 Dec;13(6):1674-1688 - PubMed
  19. Front Aging Neurosci. 2014 Nov 07;6:301 - PubMed
  20. J Int Neuropsychol Soc. 2014 Apr;20(4):391-401 - PubMed
  21. EMBO Mol Med. 2020 Jun 8;12(6):e12075 - PubMed
  22. Neuropsychol Rev. 2014 Mar;24(1):49-62 - PubMed
  23. Neurology. 2013 Mar 12;80(11 Suppl 3):S2-6 - PubMed
  24. Neurology. 2013 Mar 12;80(11 Suppl 3):S54-64 - PubMed
  25. Brain Imaging Behav. 2013 Dec;7(4):524-32 - PubMed
  26. Exp Gerontol. 2015 Apr;64:78-80 - PubMed
  27. Oncologist. 2007 Jan;12(1):20-37 - PubMed
  28. Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13848-53 - PubMed
  29. Annu Rev Clin Psychol. 2018 May 7;14:425-451 - PubMed
  30. Alzheimers Res Ther. 2012 Mar 15;4(2):8 - PubMed
  31. J Natl Cancer Inst. 2018 Mar 1;110(3):223-231 - PubMed
  32. Neuroimage. 2010 Mar;50(1):48-55 - PubMed
  33. Neuroradiology. 2016 Sep;58(9):921-8 - PubMed
  34. Neuroimage. 2017 Oct 15;160:32-40 - PubMed
  35. Cancer. 2016 Nov 15;122(22):3555-3563 - PubMed
  36. Breast Cancer Res Treat. 2018 Nov;172(2):363-370 - PubMed
  37. PLoS One. 2020 May 4;15(5):e0232548 - PubMed
  38. Nat Rev Neurosci. 2007 Sep;8(9):700-11 - PubMed
  39. Neuroimage. 2012 Aug 15;62(2):881-6 - PubMed
  40. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:77-83 - PubMed
  41. Neurobiol Dis. 2012 Dec;48(3):329-38 - PubMed
  42. Lancet Oncol. 2011 Jul;12(7):703-8 - PubMed

Publication Types

Grant support